US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

5.16

-0.0300-0.58%

Post-market: 5.160.00000.00%16:20 EDT

Volume:1.81M

Turnover:9.29M

Market Cap:458.19M

PE:-2.20

High:5.26

Open:5.20

Low:4.99

Close:5.19

Loading ...

Overview Company News Filings

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Verve Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Verve Therapeutics price target raised to $15 from $14 at H.C. Wainwright

Verve Therapeutics Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

Verve Therapeutics (VERV) Reports Q4 Loss, Tops Revenue Estimates

Verve Therapeutics: Q4 Earnings Snapshot

Associated Press Finance

BRIEF-Verve Therapeutics Q4 EPS USD -0.58

Verve Therapeutics Q4 Collaboration Revenue USD 13.08 Million

THOMSON REUTERS

Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

Promising Outlook for Verve Therapeutics: Buy Rating Backed by Innovative Treatments and Strategic Partnerships

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last?

Verve Therapeutics Inc: Initial Data for Heart-2 Phase 1B Clinical Trial of Verve-102 Targeting Pcsk9 Expected in Q2 of 2025

THOMSON REUTERS

Verve Therapeutics Inc: Well-Capitalized With Cash Runway Extending Into Mid-2027

THOMSON REUTERS

Press Release: Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Why Is Verve Therapeutics, Inc. (VERV) Among the Top CRISPR Stocks to Invest In?

Verve Therapeutics Slides As Insider Purchases Lose Another US$65k

Simply Wall St.

Stifel Nicolaus Sticks to Their Buy Rating for Verve Therapeutics (VERV)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VERV/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VERV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VERV\",,,,,undefined,":{"symbol":"VERV","market":"US","secType":"STK","nameCN":"Verve Therapeutics","latestPrice":5.16,"timestamp":1746475200000,"preClose":5.19,"halted":0,"volume":1806985,"hourTrading":{"tag":"盘后","latestPrice":5.16,"preClose":5.16,"latestTime":"16:20 EDT","volume":20842,"amount":107546.793779,"timestamp":1746476400482},"delay":0,"floatShares":64970931,"shares":88795768,"eps":-2.345416,"marketStatus":"Post-Mkt","change":-0.03,"latestTime":"05-05 16:32:37 EDT","open":5.2,"high":5.26,"low":4.99,"amount":9291981.793902,"amplitude":0.052023,"askPrice":5.16,"askSize":5,"bidPrice":5.13,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-2.345416,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746489600000},"marketStatusCode":4,"adr":0,"listingDate":1623902400000,"exchange":"NASDAQ","adjPreClose":5.19,"preHourTrading":{"tag":"盘前","latestPrice":5.2,"preClose":5.19,"latestTime":"09:28 EDT","volume":15688,"amount":82124.7299816,"timestamp":1746451710112},"postHourTrading":{"tag":"盘后","latestPrice":5.16,"preClose":5.16,"latestTime":"16:20 EDT","volume":20842,"amount":107546.793779,"timestamp":1746476400482},"volumeRatio":0.77895,"impliedVol":0.8081,"impliedVolPercentile":0.34},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VERV\",,,,,undefined,":{"symbol":"VERV","floatShares":64970931,"roa":"-20.41%","roe":"-36.36%","lyrEps":-2.345416,"volumeRatio":0.77895,"shares":88795768,"dividePrice":0,"high":5.26,"amplitude":0.052023,"preClose":5.19,"low":4.99,"week52Low":2.8647,"pbRate":"0.93","psRate":"14.17","week52High":9.305,"institutionHeld":0,"latestPrice":5.16,"eps":-2.345416,"divideRate":0,"volume":1806985,"delay":0,"ttmEps":-2.345416,"open":5.2,"prevYearClose":5.64,"prevWeekClose":5.19,"prevMonthClose":5.67,"prevQuarterClose":4.57,"fiveDayClose":5.73,"twentyDayClose":3.62,"sixtyDayClose":8.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VERV\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516663286","title":"Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663286","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516663286?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:05","pubTimestamp":1741035900,"startTime":"0","endTime":"0","summary":"BOSTON, March  03, 2025  (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on February 28, 2","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3036024/0/en/Verve-Therapeutics-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV","BK4585","IE00B64PRP62.GBP","SQQQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","QID","BK4539","BK4588","NVIW.SI","NQmain","BK4112","USAW.SI","BK4139","QLD",".IXIC","NDAQ","TSYW.SI","LU2210150020.SGD","LU2095319765.USD","MNQmain","LU2210149790.SGD","USJW.SI","PSQ","IE00BGHQF748.EUR","TQQQ"],"gpt_icon":1},{"id":"2514329754","title":"Verve Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2514329754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514329754?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:40","pubTimestamp":1740746400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VERV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 28, 2025 07:40 ET (12:40 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV"],"gpt_icon":0},{"id":"2514340311","title":"Verve Therapeutics price target raised to $15 from $14 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2514340311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514340311?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:20","pubTimestamp":1740741646,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Mitchell Kapoor raised the firm’s price target on Verve Therapeutics (VERV) to $15 from $14 and keeps a Buy rating on the s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verve-therapeutics-price-target-raised-to-15-from-14-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verve-therapeutics-price-target-raised-to-15-from-14-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2514734197","title":"Verve Therapeutics Full Year 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2514734197","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514734197?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:08","pubTimestamp":1740737304,"startTime":"0","endTime":"0","summary":"NasdaqGS:VERV Earnings and Revenue Growth February 28th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 36%. Earnings per share  also surpassed analyst estimates by 6.0%.Looking ahead, revenue is expected to decline by 9.0% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 20%.The company's shares are down 21% from a week ago.Before we wrap up, we've discovered 3 warning signs for Verve Therapeutics (1 is concerning!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verve-therapeutics-full-2024-earnings-100824906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VERV"],"gpt_icon":0},{"id":"2514381860","title":"Verve Therapeutics (VERV) Reports Q4 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381860","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514381860?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:25","pubTimestamp":1740662706,"startTime":"0","endTime":"0","summary":"Verve Therapeutics  came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.69 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 19.44%. A quarter ago, it was expected that this biotechnology firm would post a loss of $0.70 per share when it actually produced a loss of $0.59, delivering a surprise of 15.71%.Verve Therapeutics , which belongs to the Zacks Medical - Drugs industry, posted revenues of $13.08 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 90.39%. This compares to year-ago revenues of $5.14 million. The company has topped consensus revenue estimates three times over the last four quarters.Verve Therapeutics shares have added about 11.9% since the beginning of the year versus the S&P 500's gain of 1.3%.While Verve Therapeutics has outperformed the market so far this year, the que","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verve-therapeutics-verv-reports-q4-132506459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VERV"],"gpt_icon":0},{"id":"2514801360","title":"Verve Therapeutics: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801360","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514801360?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:32","pubTimestamp":1740659554,"startTime":"0","endTime":"0","summary":"BOSTON  — BOSTON  — Verve Therapeutics Inc.  on Thursday reported a loss of $50 million in its fourth quarter.The Boston-based company said it had a loss of 58 cents per share.The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.The biotechnology firm posted revenue of $13.1 million in the period.For the year, the company reported a loss of $198.7 million, or $2.35 per share. Revenue was reported as $32.3 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verve-therapeutics-q4-earnings-snapshot-123234408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VERV"],"gpt_icon":0},{"id":"2514380585","title":"BRIEF-Verve Therapeutics Q4 EPS USD -0.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380585","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514380585?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657646,"startTime":"0","endTime":"0","summary":"BRIEF-Verve Therapeutics Q4 EPS USD -0.58\n\n\nFeb 27 (Reuters) - Verve Therapeutics Q4 collaboration revenue USD 13.08 million.\n\nQ4 net income USD -50.035 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLX56ED6B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV"],"gpt_icon":0},{"id":"2514803708","title":"Verve Therapeutics Q4 Collaboration Revenue USD 13.08 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514803708","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514803708?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLX56ED6B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","VERV"],"gpt_icon":0},{"id":"2514806562","title":"Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514806562","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514806562?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"Initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in the second quarter of 2025, with final dose escalation data in the second half of 2025 VERVE-102 has been","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033688/0/en/Verve-Therapeutics-Announces-Pipeline-Progress-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4178","BK4539","BK4139","BK4559","BK4097","BK4585","PRGS","VERV","LU2065732104.USD","BK4588","RH"],"gpt_icon":0},{"id":"2513571291","title":"Promising Outlook for Verve Therapeutics: Buy Rating Backed by Innovative Treatments and Strategic Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2513571291","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513571291?lang=en_us&edition=fundamental","pubTime":"2025-02-21 23:15","pubTimestamp":1740150912,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on VERV stock, giving a Buy rating yesterday. Myles Minter has given his Buy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-outlook-for-verve-therapeutics-buy-rating-backed-by-innovative-treatments-and-strategic-partnerships?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-outlook-for-verve-therapeutics-buy-rating-backed-by-innovative-treatments-and-strategic-partnerships?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV"],"gpt_icon":0},{"id":"2508789311","title":"Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2508789311","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508789311?lang=en_us&edition=fundamental","pubTime":"2025-02-04 05:05","pubTimestamp":1738616700,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  03, 2025  (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on January 31, 202","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/03/3019852/0/en/Verve-Therapeutics-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","USAW.SI","IE00BKPKM429.USD","TQQQ","IE00BGHQF748.EUR","QID","LU2210150020.SGD","VERV","BK4588","USJW.SI","SQQQ","BK4539","IE00B3QW5Z07.USD","BK4585","NQmain","LU2095319765.USD","NDAQ","NVIW.SI","BK4112","MNQmain",".IXIC","QLD","BK4139","LU2210149790.SGD","TSYW.SI","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2507687851","title":"Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507687851","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507687851?lang=en_us&edition=fundamental","pubTime":"2025-01-29 20:00","pubTimestamp":1738152000,"startTime":"0","endTime":"0","summary":"BOSTON, Jan. 29, 2025  -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer, will participate in a fireside chat at the Guggenheim Securities SMID Cap Biotech Conference on Wednesday, February 5, 2025 at 9 a.m. ET in New York.A live webcast will be available in the investor section of the company’s website at www.vervetx.com. The webcast will be archived for 90 days following the presentation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verve-therapeutics-participate-guggenheim-securities-120000499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SMID","VERV","BK4139","BK4539","BK4011"],"gpt_icon":0},{"id":"2505004899","title":"Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last?","url":"https://stock-news.laohu8.com/highlight/detail?id=2505004899","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505004899?lang=en_us&edition=fundamental","pubTime":"2025-01-23 22:31","pubTimestamp":1737642660,"startTime":"0","endTime":"0","summary":"Verve Therapeutics  shares rallied 18.7% in the last trading session to close at $7.80. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 13.9% gain over the past four weeks.This biotechnology firm is expected to post quarterly loss of $0.72 per share in its upcoming report, which represents a year-over-year change of -4.4%. Revenues are expected to be $6.87 million, up 33.7% from the year-ago quarter.For Verve Therapeutics, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on VERV going forward to see if this recent jump can turn into more strength down the road.Verve Therapeutics is part of the Zacks Medical - Drugs industry. Karyopharm Therapeutics , another stock in the same industry, closed the last tradi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verve-therapeutics-verv-moves-18-143100609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4139","KPTI","VERV"],"gpt_icon":0},{"id":"2503308074","title":"Verve Therapeutics Inc: Initial Data for Heart-2 Phase 1B Clinical Trial of Verve-102 Targeting Pcsk9 Expected in Q2 of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503308074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503308074?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:07","pubTimestamp":1736770035,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90PN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VERV","BK4539","BK4139"],"gpt_icon":0},{"id":"2503308070","title":"Verve Therapeutics Inc: Well-Capitalized With Cash Runway Extending Into Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2503308070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503308070?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:07","pubTimestamp":1736770035,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nFWN3O90PN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","VERV"],"gpt_icon":0},{"id":"2503308269","title":"Press Release: Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2503308269","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503308269?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:00","pubTimestamp":1736769600,"startTime":"0","endTime":"0","summary":"Initial data for the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in second quarter of 2025. Dosing in the Heart-2 trial has moved to the 0.6 mg/kg cohort. VERVE-301 nominated as development candidate targeting the LPA gene; Verve to receive an associated milestone payment from Eli Lilly. Company to present at 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 2:15 p.m. ET/11:15 a.m. PT. BOSTON, Jan. 13, 2025  --  Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today highlighted its recent pipeline progress and anticipated 2025 milestones.Initial Data for the Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102 Expected in the Second Quarter of 2025. -- VERVE-102, a novel, investigational base editing medicine targeting. PCSK9, is being evaluated in the Heart-2 open-label Phase 1b clinical. trial in two patient populations who require deep and durable reductions. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VERV","BK4559","BK4588","BK4539","BK4139","BK4097","LU2065732104.USD","PRGS","RH","BK4178"],"gpt_icon":0},{"id":"2500712922","title":"Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2500712922","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500712922?lang=en_us&edition=fundamental","pubTime":"2025-01-04 05:05","pubTimestamp":1735938300,"startTime":"0","endTime":"0","summary":"BOSTON, Jan.  03, 2025  (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on December 31, 20","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/03/3004162/0/en/Verve-Therapeutics-Announces-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERV","USJW.SI","BK4585","IE00B3QW5Z07.USD","QID","PSQ","NVIW.SI","NDAQ","LU2210150020.SGD","IE00B64PRP62.GBP","QLD","LU2210149790.SGD","NQmain","IE00BGHQF748.EUR","IE00BKPKM429.USD",".IXIC","TSYW.SI","BK4588","MNQmain","TQQQ","USAW.SI","BK4139","BK4112","LU2095319765.USD","SQQQ","BK4539"],"gpt_icon":1},{"id":"2495065095","title":"Why Is Verve Therapeutics, Inc. (VERV) Among the Top CRISPR Stocks to Invest In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2495065095","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495065095?lang=en_us&edition=fundamental","pubTime":"2024-12-31 04:29","pubTimestamp":1735590586,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the Top 11 CRISPR Stocks to Invest In.In this article, we are going to take a look at where Verve Therapeutics, Inc. stands against the other CRISPR stocks.The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital therapeutics, and artificial intelligence. Among the most exciting breakthroughs are gene therapy and gene editing, with CRISPR-Cas9 leading the charge. This remarkable tool, inspired by bacteria's natural defenses, acts like precise genetic scissors—faster, cheaper, and more accurate than other genome-editing methods.The regulatory landscape for gene and regenerative therapies has also come a long way. In the U.S., the FDA has created clearer pathways for development, aided by the Regenerative Medicine Advanced Therapy  designation, which speeds up re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-verve-therapeutics-inc-verv-202946847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585",".IXIC","BK4539","BK4139","TSYW.SI","LU1861558580.USD","NQmain","LU1861559042.SGD","VERV","TQQQ","CRSP","BK4556","QLD","PSQ","USJW.SI","QID","SQQQ","NVIW.SI","MNQmain","USAW.SI","BK4588"],"gpt_icon":1},{"id":"2492958884","title":"Verve Therapeutics Slides As Insider Purchases Lose Another US$65k","url":"https://stock-news.laohu8.com/highlight/detail?id=2492958884","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492958884?lang=en_us&edition=fundamental","pubTime":"2024-12-17 18:08","pubTimestamp":1734430134,"startTime":"0","endTime":"0","summary":"Insiders who bought US$475.8k worth of Verve Therapeutics, Inc.'s  stock at an average buy price of US$6.26 over the last year may be disappointed by the recent 25% decrease in the stock. Insiders purchase with the hope of seeing their investments increase in value over time. However, due to recent losses, their initial investment is now only worth US$411.2k, which is not great.While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.The Last 12 Months Of Insider Transactions At Verve Therapeutics. It doesn't really mean much that no insider has traded Verve Therapeutics shares in the last quarter. But insiders have shown more of an appetite for the stock, over the last year. Insiders do have a stake in Verve Therapeutics and their transactions don't cause us concern. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verve-therapeutics-slides-insider-purchases-100854541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4539","VERV"],"gpt_icon":0},{"id":"2490418350","title":"Stifel Nicolaus Sticks to Their Buy Rating for Verve Therapeutics (VERV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490418350","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490418350?lang=en_us&edition=fundamental","pubTime":"2024-12-11 01:55","pubTimestamp":1733853317,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Dae Gon Ha maintained a Buy rating on Verve Therapeutics (VERV – Research Report) today. The company’s shares opened today ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-buy-rating-for-verve-therapeutics-verv?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-buy-rating-for-verve-therapeutics-verv?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERV","SF"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":82,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VERV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-12","symbol":"VERV","fiscalQuarterEnding":"2021/06","expectedEps":-0.53,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-2.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VERV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VERV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VERV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VERV","date":"2025-05-02","current":-2.457748,"percent":0.878852,"low":-62.162259,"twenty":-14.939571,"median":-6.102709,"eighty":-2.742876,"high":-1.327184,"avg":-9.911598,"sd":10.339975,"marketCap":488376724},"quantilePoints":[{"date":"2021-06-18","current":-32.654395,"twenty":-29.497947,"median":-21.167295,"eighty":-14.940941,"marketCap":1742569153},{"date":"2021-06-25","current":-32.306422,"twenty":-33.28127,"median":-32.654395,"eighty":-22.412565,"marketCap":1723999890},{"date":"2021-07-02","current":-45.008169,"twenty":-46.085349,"median":-33.298325,"eighty":-30.341312,"marketCap":2401815906},{"date":"2021-07-09","current":-41.291898,"twenty":-44.182331,"median":-37.719251,"eighty":-32.445611,"marketCap":2203500832},{"date":"2021-07-16","current":-43.598858,"twenty":-44.860954,"median":-41.51631,"eighty":-32.65883,"marketCap":2326609465},{"date":"2021-07-23","current":-46.938116,"twenty":-46.880666,"median":-42.889715,"eighty":-32.884508,"marketCap":2504805619},{"date":"2021-07-30","current":-53.347337,"twenty":-47.706504,"median":-43.598858,"eighty":-33.28127,"marketCap":2846827270},{"date":"2021-08-06","current":-61.112009,"twenty":-51.440728,"median":-44.909427,"eighty":-34.047863,"marketCap":3261181231},{"date":"2021-08-13","current":-29.159869,"twenty":-53.788981,"median":-45.008169,"eighty":-33.28127,"marketCap":2879507940},{"date":"2021-08-20","current":-30.768522,"twenty":-53.002639,"median":-44.119495,"eighty":-31.587801,"marketCap":3038360794},{"date":"2021-08-27","current":-34.180227,"twenty":-51.440728,"median":-42.943574,"eighty":-31.289512,"marketCap":3375263223},{"date":"2021-09-03","current":-34.695385,"twenty":-49.403063,"median":-41.704816,"eighty":-31.582083,"marketCap":3426134530},{"date":"2021-09-10","current":-35.958979,"twenty":-48.686738,"median":-40.843073,"eighty":-31.68803,"marketCap":3550913208},{"date":"2021-09-17","current":-29.10155,"twenty":-48.45694,"median":-35.6042,"eighty":-31.158293,"marketCap":2873748924},{"date":"2021-09-24","current":-23.293876,"twenty":-47.7083,"median":-34.712395,"eighty":-30.238785,"marketCap":2300246926},{"date":"2021-10-01","current":-24.110352,"twenty":-47.589809,"median":-34.243407,"eighty":-29.159869,"marketCap":2380873148},{"date":"2021-10-08","current":-21.354744,"twenty":-47.103283,"median":-34.027137,"eighty":-25.692351,"marketCap":2108759648},{"date":"2021-10-15","current":-21.349884,"twenty":-46.909391,"median":-33.383602,"eighty":-24.247403,"marketCap":2108279730},{"date":"2021-10-22","current":-20.761827,"twenty":-46.605986,"median":-32.917417,"eighty":-23.323036,"marketCap":2050209653},{"date":"2021-10-29","current":-22.545439,"twenty":-45.812463,"median":-32.306422,"eighty":-22.932294,"marketCap":2226339555},{"date":"2021-11-05","current":-26.136963,"twenty":-45.525215,"median":-31.587429,"eighty":-23.25694,"marketCap":2580998950},{"date":"2021-11-12","current":-20.667105,"twenty":-44.968672,"median":-31.108721,"eighty":-22.843842,"marketCap":2325214652},{"date":"2021-11-19","current":-17.682856,"twenty":-44.776575,"median":-30.600853,"eighty":-22.274252,"marketCap":1989462713},{"date":"2021-11-26","current":-14.193382,"twenty":-44.640132,"median":-30.158595,"eighty":-21.777562,"marketCap":1596868981},{"date":"2021-12-03","current":-13.675313,"twenty":-43.598858,"median":-29.159869,"eighty":-21.369324,"marketCap":1538582059},{"date":"2021-12-10","current":-13.983585,"twenty":-43.266728,"median":-28.931451,"eighty":-21.087446,"marketCap":1573265186},{"date":"2021-12-17","current":-16.813698,"twenty":-42.943574,"median":-26.642401,"eighty":-20.667105,"marketCap":1891675562},{"date":"2021-12-23","current":-17.691419,"twenty":-42.8574,"median":-26.136963,"eighty":-17.715396,"marketCap":1990426133},{"date":"2021-12-31","current":-15.786123,"twenty":-42.08183,"median":-25.274317,"eighty":-17.274395,"marketCap":1776065138},{"date":"2022-01-07","current":-13.72241,"twenty":-41.591713,"median":-24.46513,"eighty":-16.775164,"marketCap":1543880870},{"date":"2022-01-14","current":-14.039245,"twenty":-41.33678,"median":-24.246431,"eighty":-15.710768,"marketCap":1579527417},{"date":"2022-01-21","current":-13.923643,"twenty":-40.753308,"median":-24.188111,"eighty":-15.395644,"marketCap":1566521245},{"date":"2022-01-28","current":-12.176765,"twenty":-37.733087,"median":-23.439675,"eighty":-14.983072,"marketCap":1369983524},{"date":"2022-02-04","current":-11.551657,"twenty":-35.746112,"median":-23.279296,"eighty":-14.684049,"marketCap":1299653849},{"date":"2022-02-11","current":-13.247156,"twenty":-35.268232,"median":-22.851618,"eighty":-14.251611,"marketCap":1490411049},{"date":"2022-02-18","current":-11.457463,"twenty":-34.855344,"median":-22.538149,"eighty":-14.189957,"marketCap":1289056227},{"date":"2022-02-25","current":-13.170088,"twenty":-34.715796,"median":-22.29758,"eighty":-14.064935,"marketCap":1481740267},{"date":"2022-03-04","current":-11.838522,"twenty":-34.561249,"median":-22.030281,"eighty":-13.877402,"marketCap":1331928426},{"date":"2022-03-11","current":-11.247666,"twenty":-34.31339,"median":-21.692513,"eighty":-13.701858,"marketCap":1265452432},{"date":"2022-03-18","current":-10.085637,"twenty":-34.218135,"median":-21.369324,"eighty":-13.587969,"marketCap":1213443343},{"date":"2022-03-25","current":-9.443677,"twenty":-34.129683,"median":-21.228995,"eighty":-13.23945,"marketCap":1136206557},{"date":"2022-04-01","current":-9.088378,"twenty":-34.032483,"median":-20.922206,"eighty":-13.160668,"marketCap":1093459153},{"date":"2022-04-08","current":-7.917508,"twenty":-33.982912,"median":-20.714466,"eighty":-12.679421,"marketCap":952587027},{"date":"2022-04-14","current":-8.208207,"twenty":-33.842055,"median":-19.47469,"eighty":-12.374573,"marketCap":987562176},{"date":"2022-04-22","current":-6.665887,"twenty":-33.349491,"median":-17.691419,"eighty":-12.192179,"marketCap":801999583},{"date":"2022-04-29","current":-6.034246,"twenty":-33.204309,"median":-17.492326,"eighty":-11.914733,"marketCap":726004260},{"date":"2022-05-06","current":-5.334565,"twenty":-33.068577,"median":-16.852232,"eighty":-11.563646,"marketCap":641822801},{"date":"2022-05-13","current":-4.869088,"twenty":-32.663265,"median":-16.76232,"eighty":-11.392383,"marketCap":668121653},{"date":"2022-05-20","current":-4.755606,"twenty":-32.5848,"median":-16.150056,"eighty":-10.105824,"marketCap":652549990},{"date":"2022-05-27","current":-5.54998,"twenty":-32.241841,"median":-15.409346,"eighty":-9.616481,"marketCap":761551629},{"date":"2022-06-03","current":-5.170525,"twenty":-31.983517,"median":-15.39436,"eighty":-9.354852,"marketCap":709483882},{"date":"2022-06-10","current":-4.471901,"twenty":-31.614158,"median":-15.302306,"eighty":-9.088378,"marketCap":613620834},{"date":"2022-06-17","current":-4.486086,"twenty":-31.560699,"median":-14.940941,"eighty":-8.446418,"marketCap":615567291},{"date":"2022-06-24","current":-5.993269,"twenty":-31.397404,"median":-14.839897,"eighty":-8.028942,"marketCap":822378437},{"date":"2022-07-01","current":-5.542888,"twenty":-31.158293,"median":-14.347518,"eighty":-7.642151,"marketCap":760578400},{"date":"2022-07-08","current":-7.528823,"twenty":-30.94251,"median":-14.261887,"eighty":-7.437047,"marketCap":1033082498},{"date":"2022-07-15","current":-8.408309,"twenty":-30.793794,"median":-14.208367,"eighty":-7.437047,"marketCap":1153762884},{"date":"2022-07-22","current":-12.715115,"twenty":-30.567319,"median":-14.184819,"eighty":-7.498573,"marketCap":1744729900},{"date":"2022-07-29","current":-10.451203,"twenty":-30.287385,"median":-14.071357,"eighty":-7.594882,"marketCap":1434082747},{"date":"2022-08-05","current":-11.321429,"twenty":-30.152277,"median":-13.979303,"eighty":-7.641344,"marketCap":1553492562},{"date":"2022-08-12","current":-17.039792,"twenty":-29.572967,"median":-13.981444,"eighty":-7.645381,"marketCap":2133347845},{"date":"2022-08-19","current":-16.029565,"twenty":-29.177365,"median":-14.103469,"eighty":-7.782487,"marketCap":2006869509},{"date":"2022-08-26","current":-18.777764,"twenty":-29.159869,"median":-14.1891,"eighty":-7.899631,"marketCap":2350938535},{"date":"2022-09-02","current":-17.595177,"twenty":-29.124878,"median":-14.210508,"eighty":-7.970802,"marketCap":2202880958},{"date":"2022-09-09","current":-18.552738,"twenty":-28.96547,"median":-14.261887,"eighty":-8.017637,"marketCap":2322765636},{"date":"2022-09-16","current":-17.499421,"twenty":-28.21427,"median":-14.469542,"eighty":-8.09758,"marketCap":2190892490},{"date":"2022-09-23","current":-16.854037,"twenty":-27.093149,"median":-14.934092,"eighty":-8.198517,"marketCap":2110091673},{"date":"2022-09-30","current":-16.498608,"twenty":-26.578249,"median":-14.95128,"eighty":-8.288248,"marketCap":2065592732},{"date":"2022-10-07","current":-16.090346,"twenty":-26.343998,"median":-15.287456,"eighty":-8.423553,"marketCap":2014479084},{"date":"2022-10-14","current":-14.678238,"twenty":-25.973668,"median":-15.294881,"eighty":-8.459338,"marketCap":1837685994},{"date":"2022-10-21","current":-15.369882,"twenty":-25.549878,"median":-15.302306,"eighty":-8.480333,"marketCap":1924278528},{"date":"2022-10-28","current":-19.548569,"twenty":-25.275775,"median":-15.343465,"eighty":-8.522485,"marketCap":2447441752},{"date":"2022-11-04","current":-15.028863,"twenty":-25.226203,"median":-15.387938,"eighty":-8.690928,"marketCap":1881583598},{"date":"2022-11-11","current":-11.266009,"twenty":-24.885032,"median":-15.309677,"eighty":-8.584128,"marketCap":1663302276},{"date":"2022-11-18","current":-9.768047,"twenty":-24.38737,"median":-15.287456,"eighty":-8.694003,"marketCap":1442144677},{"date":"2022-11-25","current":-9.304889,"twenty":-24.266843,"median":-15.048075,"eighty":-8.868577,"marketCap":1373764472},{"date":"2022-12-02","current":-10.01423,"twenty":-24.249347,"median":-14.98639,"eighty":-8.955101,"marketCap":1478490912},{"date":"2022-12-09","current":-9.03367,"twenty":-24.240599,"median":-14.940941,"eighty":-8.928396,"marketCap":1333722010},{"date":"2022-12-16","current":-8.040592,"twenty":-24.217271,"median":-14.796025,"eighty":-8.868577,"marketCap":1187104994},{"date":"2022-12-23","current":-7.598297,"twenty":-24.13368,"median":-14.591567,"eighty":-8.50262,"marketCap":1121804979},{"date":"2022-12-30","current":-8.073973,"twenty":-24.110352,"median":-14.330392,"eighty":-8.408309,"marketCap":1192033297},{"date":"2023-01-06","current":-8.528786,"twenty":-23.57381,"median":-14.236197,"eighty":-8.324328,"marketCap":1259181426},{"date":"2023-01-13","current":-9.571935,"twenty":-23.377467,"median":-14.199804,"eighty":-8.39652,"marketCap":1413190896},{"date":"2023-01-20","current":-9.008634,"twenty":-23.321092,"median":-14.180537,"eighty":-8.415502,"marketCap":1330025782},{"date":"2023-01-27","current":-9.35496,"twenty":-23.27638,"median":-14.039245,"eighty":-8.43597,"marketCap":1381156926},{"date":"2023-02-03","current":-9.717976,"twenty":-23.258884,"median":-13.951473,"eighty":-8.450775,"marketCap":1434752222},{"date":"2023-02-10","current":-8.532959,"twenty":-23.012969,"median":-13.782352,"eighty":-8.468702,"marketCap":1259797464},{"date":"2023-02-17","current":-8.804177,"twenty":-22.845786,"median":-13.705284,"eighty":-8.481141,"marketCap":1299839926},{"date":"2023-02-24","current":-7.769373,"twenty":-22.723314,"median":-13.652144,"eighty":-8.430746,"marketCap":1147062532},{"date":"2023-03-03","current":-7.649257,"twenty":-22.539607,"median":-13.611089,"eighty":-8.272588,"marketCap":1203893669},{"date":"2023-03-10","current":-6.710288,"twenty":-22.453099,"median":-13.493526,"eighty":-8.148245,"marketCap":1056112166},{"date":"2023-03-17","current":-6.474564,"twenty":-22.305356,"median":-13.247156,"eighty":-8.017637,"marketCap":1019012207},{"date":"2023-03-24","current":-5.665244,"twenty":-22.206212,"median":-13.178651,"eighty":-7.921708,"marketCap":891635681},{"date":"2023-03-31","current":-5.665244,"twenty":-22.088601,"median":-13.157243,"eighty":-7.889544,"marketCap":891635681},{"date":"2023-04-06","current":-5.24094,"twenty":-21.979737,"median":-12.934602,"eighty":-7.787733,"marketCap":824855755},{"date":"2023-04-14","current":-6.164194,"twenty":-21.772702,"median":-12.704975,"eighty":-7.643766,"marketCap":970163927},{"date":"2023-04-21","current":-6.223125,"twenty":-21.728963,"median":-12.641626,"eighty":-7.541049,"marketCap":979438917},{"date":"2023-04-28","current":-6.183837,"twenty":-21.601631,"median":-12.414392,"eighty":-7.449107,"marketCap":973255591},{"date":"2023-05-05","current":-6.416544,"twenty":-21.458748,"median":-12.339465,"eighty":-7.283557,"marketCap":1009880688},{"date":"2023-05-12","current":-7.140422,"twenty":-21.366408,"median":-12.2153,"eighty":-7.056792,"marketCap":1123809594},{"date":"2023-05-19","current":-5.645987,"twenty":-21.353772,"median":-12.005503,"eighty":-6.84703,"marketCap":1011738224},{"date":"2023-05-26","current":-5.484703,"twenty":-21.301528,"median":-11.932716,"eighty":-6.700859,"marketCap":982836796},{"date":"2023-06-02","current":-5.325726,"twenty":-21.108106,"median":-11.766756,"eighty":-6.635642,"marketCap":954348773},{"date":"2023-06-09","current":-6.079138,"twenty":-21.087446,"median":-11.594473,"eighty":-6.416544,"marketCap":1089357231},{"date":"2023-06-16","current":-6.856742,"twenty":-20.922206,"median":-11.547376,"eighty":-6.377203,"marketCap":1228700822},{"date":"2023-06-23","current":-6.44202,"twenty":-20.820883,"median":-11.495572,"eighty":-6.386645,"marketCap":1154384240},{"date":"2023-06-30","current":-6.486948,"twenty":-20.775317,"median":-11.413579,"eighty":-6.384285,"marketCap":1162435203},{"date":"2023-07-07","current":-6.421284,"twenty":-20.723938,"median":-11.293719,"eighty":-6.391554,"marketCap":1150668411},{"date":"2023-07-14","current":-7.036455,"twenty":-20.346101,"median":-11.243385,"eighty":-6.401592,"marketCap":1260904674},{"date":"2023-07-21","current":-6.853286,"twenty":-19.830124,"median":-11.037127,"eighty":-6.413167,"marketCap":1228081517},{"date":"2023-07-28","current":-6.725414,"twenty":-19.745125,"median":-10.451203,"eighty":-6.41844,"marketCap":1205167238},{"date":"2023-08-04","current":-6.538789,"twenty":-19.636542,"median":-10.136105,"eighty":-6.422166,"marketCap":1171724776},{"date":"2023-08-11","current":-5.966628,"twenty":-19.456656,"median":-10.018403,"eighty":-6.401592,"marketCap":1146982734},{"date":"2023-08-18","current":-4.829654,"twenty":-19.292947,"median":-9.773418,"eighty":-6.367993,"marketCap":928418801},{"date":"2023-08-25","current":-4.425249,"twenty":-19.23598,"median":-9.717976,"eighty":-6.300434,"marketCap":850678861},{"date":"2023-09-01","current":-4.266139,"twenty":-19.174195,"median":-9.705786,"eighty":-6.25816,"marketCap":820092654},{"date":"2023-09-08","current":-4.173325,"twenty":-19.114826,"median":-9.685396,"eighty":-6.236766,"marketCap":802250701},{"date":"2023-09-15","current":-4.279398,"twenty":-19.0229,"median":-9.601139,"eighty":-6.205112,"marketCap":822641505},{"date":"2023-09-22","current":-4.126917,"twenty":-18.777764,"median":-9.571935,"eighty":-6.17598,"marketCap":793329724},{"date":"2023-09-29","current":-4.295972,"twenty":-18.642748,"median":-9.496828,"eighty":-6.102833,"marketCap":825827568},{"date":"2023-10-06","current":-4.00427,"twenty":-18.530714,"median":-9.463447,"eighty":-6.065314,"marketCap":769752857},{"date":"2023-10-13","current":-3.815327,"twenty":-18.44166,"median":-9.432153,"eighty":-6.005773,"marketCap":733431737},{"date":"2023-10-20","current":-3.193803,"twenty":-18.423467,"median":-9.417549,"eighty":-5.961324,"marketCap":613954369},{"date":"2023-10-23","current":-3.076128,"twenty":-18.409103,"median":-9.417549,"eighty":-5.948537,"marketCap":591333320},{"date":"2023-11-02","current":-3.894882,"twenty":-18.366013,"median":-9.409204,"eighty":-5.912754,"marketCap":748724840},{"date":"2023-11-10","current":-5.303884,"twenty":-18.188865,"median":-9.371259,"eighty":-5.806678,"marketCap":1022594077},{"date":"2023-11-17","current":-3.630713,"twenty":-18.181204,"median":-9.354906,"eighty":-5.783302,"marketCap":700005173},{"date":"2023-11-24","current":-4.007673,"twenty":-18.177374,"median":-9.354852,"eighty":-5.751026,"marketCap":772683305},{"date":"2023-12-01","current":-4.594669,"twenty":-18.15535,"median":-9.317619,"eighty":-5.676693,"marketCap":885856819},{"date":"2023-12-08","current":-5.385214,"twenty":-18.119031,"median":-9.225609,"eighty":-5.662887,"marketCap":1038274679},{"date":"2023-12-15","current":-5.973375,"twenty":-17.983092,"median":-9.196401,"eighty":-5.647293,"marketCap":1151672610},{"date":"2023-12-22","current":-5.877434,"twenty":-17.786329,"median":-9.112949,"eighty":-5.647293,"marketCap":1133175075},{"date":"2023-12-29","current":-6.23617,"twenty":-17.771426,"median":-9.090397,"eighty":-5.647529,"marketCap":1202339771},{"date":"2024-01-05","current":-5.677209,"twenty":-17.741404,"median":-9.083741,"eighty":-5.647372,"marketCap":1094571524},{"date":"2024-01-12","current":-5.426928,"twenty":-17.703407,"median":-9.07331,"eighty":-5.646676,"marketCap":1046317085},{"date":"2024-01-19","current":-5.139104,"twenty":-17.687994,"median":-9.060792,"eighty":-5.637742,"marketCap":990824480},{"date":"2024-01-26","current":-4.943051,"twenty":-17.67943,"median":-9.008634,"eighty":-5.556573,"marketCap":953025170},{"date":"2024-02-02","current":-4.676085,"twenty":-17.646476,"median":-8.931885,"eighty":-5.540349,"marketCap":901553768},{"date":"2024-02-09","current":-4.926366,"twenty":-17.600923,"median":-8.854204,"eighty":-5.489345,"marketCap":949808207},{"date":"2024-02-16","current":-5.539554,"twenty":-17.558087,"median":-8.808349,"eighty":-5.424425,"marketCap":1068031583},{"date":"2024-02-23","current":-5.55624,"twenty":-17.501847,"median":-8.739502,"eighty":-5.431099,"marketCap":1071248545},{"date":"2024-03-01","current":-7.126121,"twenty":-17.490421,"median":-8.587202,"eighty":-5.450287,"marketCap":1425708706},{"date":"2024-03-08","current":-6.244237,"twenty":-17.443314,"median":-8.530873,"eighty":-5.463635,"marketCap":1249272028},{"date":"2024-03-15","current":-5.684178,"twenty":-17.398877,"median":-8.482756,"eighty":-5.478528,"marketCap":1137222194},{"date":"2024-03-22","current":-5.521176,"twenty":-17.391734,"median":-8.450048,"eighty":-5.478528,"marketCap":1104610675},{"date":"2024-03-28","current":-5.512817,"twenty":-17.363164,"median":-8.414303,"eighty":-5.460298,"marketCap":1102938290},{"date":"2024-04-05","current":-3.627843,"twenty":-17.31036,"median":-8.345192,"eighty":-5.426928,"marketCap":725815341},{"date":"2024-04-12","current":-3.372891,"twenty":-17.293545,"median":-8.200132,"eighty":-5.385214,"marketCap":674807581},{"date":"2024-04-19","current":-2.783576,"twenty":-17.276708,"median":-8.144907,"eighty":-5.349918,"marketCap":556904398},{"date":"2024-04-26","current":-2.609113,"twenty":-17.156631,"median":-8.037593,"eighty":-5.335158,"marketCap":521999934},{"date":"2024-05-03","current":-2.57975,"twenty":-17.130534,"median":-7.969658,"eighty":-5.31947,"marketCap":516125336},{"date":"2024-05-10","current":-2.713119,"twenty":-17.058943,"median":-7.92205,"eighty":-5.252726,"marketCap":534020535},{"date":"2024-05-17","current":-2.721651,"twenty":-17.039792,"median":-7.898724,"eighty":-5.220173,"marketCap":535699845},{"date":"2024-05-24","current":-2.27373,"twenty":-17.035004,"median":-7.879511,"eighty":-5.172475,"marketCap":447536077},{"date":"2024-05-31","current":-2.192678,"twenty":-17.023514,"median":-7.815272,"eighty":-5.164385,"marketCap":431582634},{"date":"2024-06-07","current":-2.252401,"twenty":-17.00915,"median":-7.649257,"eighty":-5.113676,"marketCap":443337803},{"date":"2024-06-14","current":-2.38891,"twenty":-16.914933,"median":-7.642959,"eighty":-5.054805,"marketCap":470206760},{"date":"2024-06-21","current":-2.188412,"twenty":-16.853315,"median":-7.598297,"eighty":-5.000761,"marketCap":430742979},{"date":"2024-06-28","current":-2.030573,"twenty":-16.852593,"median":-7.589952,"eighty":-4.980279,"marketCap":399675746},{"date":"2024-07-05","current":-2.192678,"twenty":-16.829112,"median":-7.514845,"eighty":-4.961403,"marketCap":431582634},{"date":"2024-07-12","current":-2.717385,"twenty":-16.795715,"median":-7.475676,"eighty":-4.926252,"marketCap":534860190},{"date":"2024-07-15","current":-2.870958,"twenty":-16.789721,"median":-7.453197,"eighty":-4.924469,"marketCap":565087767},{"date":"2024-08-02","current":-2.870958,"twenty":-16.783727,"median":-7.450641,"eighty":-4.918023,"marketCap":565087767},{"date":"2024-08-09","current":-2.389593,"twenty":-16.740912,"median":-7.389961,"eighty":-4.826532,"marketCap":460357437},{"date":"2024-08-16","current":-1.994256,"twenty":-16.733959,"median":-7.296883,"eighty":-4.801708,"marketCap":384195361},{"date":"2024-08-23","current":-2.126035,"twenty":-16.609079,"median":-7.195432,"eighty":-4.755606,"marketCap":409582720},{"date":"2024-08-30","current":-2.692685,"twenty":-16.561048,"median":-7.149294,"eighty":-4.718312,"marketCap":518748362},{"date":"2024-09-06","current":-2.429126,"twenty":-16.511096,"median":-7.124489,"eighty":-4.649992,"marketCap":467973645},{"date":"2024-09-13","current":-2.481838,"twenty":-16.497212,"median":-7.057192,"eighty":-4.594267,"marketCap":478128588},{"date":"2024-09-20","current":-2.363237,"twenty":-16.471361,"median":-7.034442,"eighty":-4.512568,"marketCap":455279966},{"date":"2024-09-27","current":-2.178746,"twenty":-16.434247,"median":-7.001895,"eighty":-4.45243,"marketCap":419737663},{"date":"2024-10-04","current":-2.073323,"twenty":-16.227702,"median":-6.929319,"eighty":-4.356537,"marketCap":399427776},{"date":"2024-10-11","current":-2.020612,"twenty":-16.165511,"median":-6.877479,"eighty":-4.305916,"marketCap":389272833},{"date":"2024-10-18","current":-2.398378,"twenty":-16.152523,"median":-6.863399,"eighty":-4.276746,"marketCap":462049928},{"date":"2024-10-25","current":-2.512587,"twenty":-16.102288,"median":-6.853286,"eighty":-4.248902,"marketCap":484052305},{"date":"2024-10-31","current":-2.543335,"twenty":-16.064409,"median":-6.836006,"eighty":-4.196586,"marketCap":489976022},{"date":"2024-11-08","current":-2.732949,"twenty":-16.036586,"median":-6.820277,"eighty":-4.165088,"marketCap":538462022},{"date":"2024-11-15","current":-2.311834,"twenty":-15.910413,"median":-6.725414,"eighty":-4.125591,"marketCap":455491459},{"date":"2024-11-22","current":-1.976661,"twenty":-15.804065,"median":-6.707483,"eighty":-4.019554,"marketCap":389453664},{"date":"2024-11-29","current":-2.410667,"twenty":-15.740665,"median":-6.694678,"eighty":-3.996315,"marketCap":474964142},{"date":"2024-12-06","current":-2.625522,"twenty":-15.671678,"median":-6.665887,"eighty":-3.89886,"marketCap":517296062},{"date":"2024-12-13","current":-2.677087,"twenty":-15.659751,"median":-6.628019,"eighty":-3.827586,"marketCap":527455723},{"date":"2024-12-20","current":-2.217298,"twenty":-15.603312,"median":-6.573349,"eighty":-3.714001,"marketCap":436865414},{"date":"2024-12-27","current":-2.707167,"twenty":-15.538951,"median":-6.557068,"eighty":-3.628417,"marketCap":533382192},{"date":"2025-01-03","current":-2.582551,"twenty":-15.523581,"median":-6.538789,"eighty":-3.560971,"marketCap":508829678},{"date":"2025-01-10","current":-2.582551,"twenty":-15.432193,"median":-6.474564,"eighty":-3.367876,"marketCap":508829678},{"date":"2025-01-17","current":-2.621225,"twenty":-15.409346,"median":-6.432755,"eighty":-3.08703,"marketCap":516449424},{"date":"2025-01-24","current":-3.433375,"twenty":-15.404208,"median":-6.418914,"eighty":-3.076481,"marketCap":676464081},{"date":"2025-01-31","current":-3.184143,"twenty":-15.393076,"median":-6.395376,"eighty":-3.084451,"marketCap":627359054},{"date":"2025-02-07","current":-3.592367,"twenty":-15.377104,"median":-6.374177,"eighty":-3.105077,"marketCap":707789702},{"date":"2025-02-14","current":-3.313056,"twenty":-15.338182,"median":-6.353599,"eighty":-3.152028,"marketCap":652758206},{"date":"2025-02-21","current":-3.364621,"twenty":-15.311151,"median":-6.327828,"eighty":-3.179529,"marketCap":662917867},{"date":"2025-02-28","current":-2.641631,"twenty":-15.302306,"median":-6.296207,"eighty":-3.081873,"marketCap":524915808},{"date":"2025-03-07","current":-2.953767,"twenty":-15.296366,"median":-6.267048,"eighty":-3.015698,"marketCap":586940026},{"date":"2025-03-14","current":-2.74821,"twenty":-15.283923,"median":-6.253996,"eighty":-2.947346,"marketCap":546093973},{"date":"2025-03-21","current":-2.475623,"twenty":-15.186404,"median":-6.244237,"eighty":-2.887812,"marketCap":491928554},{"date":"2025-03-28","current":-2.359438,"twenty":-15.04039,"median":-6.236318,"eighty":-2.869701,"marketCap":468841655},{"date":"2025-04-04","current":-1.71819,"twenty":-15.021782,"median":-6.213689,"eighty":-2.823583,"marketCap":341419727},{"date":"2025-04-11","current":-1.362933,"twenty":-14.991344,"median":-6.203518,"eighty":-2.777216,"marketCap":270827092},{"date":"2025-04-17","current":-2.015354,"twenty":-14.957484,"median":-6.183646,"eighty":-2.758732,"marketCap":400468913},{"date":"2025-04-25","current":-2.58287,"twenty":-14.940941,"median":-6.17598,"eighty":-2.754435,"marketCap":513239539},{"date":"2025-05-02","current":-2.457748,"twenty":-14.939571,"median":-6.102709,"eighty":-2.742876,"marketCap":488376724}],"updateTime":1746443195283}}}